|
US5132418A
(en)
|
1980-02-29 |
1992-07-21 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4500707A
(en)
|
1980-02-29 |
1985-02-19 |
University Patents, Inc. |
Nucleosides useful in the preparation of polynucleotides
|
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4668777A
(en)
|
1981-03-27 |
1987-05-26 |
University Patents, Inc. |
Phosphoramidite nucleoside compounds
|
|
US4973679A
(en)
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
|
US4415732A
(en)
|
1981-03-27 |
1983-11-15 |
University Patents, Inc. |
Phosphoramidite compounds and processes
|
|
US4373071A
(en)
|
1981-04-30 |
1983-02-08 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US4401796A
(en)
|
1981-04-30 |
1983-08-30 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US5153319A
(en)
|
1986-03-31 |
1992-10-06 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5047524A
(en)
|
1988-12-21 |
1991-09-10 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5700642A
(en)
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
|
US8137910B2
(en)
|
2002-05-03 |
2012-03-20 |
Duke University |
Method of regulating gene expression
|
|
US8106180B2
(en)
*
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
WO2005017145A1
(ja)
|
2003-08-13 |
2005-02-24 |
Japan Biological Informatics Consortium |
機能性ｒｎａが制御する被制御遺伝子の同定・予測方法及びその利用方法
|
|
US7795419B2
(en)
*
|
2004-05-26 |
2010-09-14 |
Rosetta Genomics Ltd. |
Viral and viral associated miRNAs and uses thereof
|
|
EP1838870A2
(en)
|
2004-12-29 |
2007-10-03 |
Exiqon A/S |
NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF MICRORNAS AND THEIR TARGET MRNAs
|
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
WO2006133022A2
(en)
|
2005-06-03 |
2006-12-14 |
The Johns Hopkins University |
Compositions and methods for decreasing microrna expression for the treatment of neoplasia
|
|
ITMI20051248A1
(it)
|
2005-07-01 |
2007-01-02 |
Vimar Spa |
Modem per bus per impianti elettrici civili ed industriali
|
|
JP2009507918A
(ja)
|
2005-09-12 |
2009-02-26 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
Ｂｃｌ２関連癌の診断及び療法のための組成物及び方法
|
|
US8603991B2
(en)
|
2005-11-18 |
2013-12-10 |
Gradalis, Inc. |
Individualized cancer therapy
|
|
KR101485071B1
(ko)
|
2005-12-12 |
2015-01-26 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
마이크로 ｒｎａ를 이용한 근육 세포 증식 및 분화 조절방법과 근육 세포 치료방법 및 유전자 발현 억제방법그리고 마이크로 ｒｎａ 분자의 발현용 벡터와 이를 이용한키트 및 미오사이트
|
|
EP1969147B1
(en)
|
2006-01-05 |
2014-07-30 |
The Ohio State University Research Foundation |
microRNA-based methods for the diagnosis of stomach cancer
|
|
WO2007143752A2
(en)
|
2006-06-09 |
2007-12-13 |
The Regents Of The University Of California |
Targets in breast cancer for prognosis or therapy
|
|
US20100292299A1
(en)
|
2006-06-20 |
2010-11-18 |
Mendell Joshua T |
Nucleotide Motifs Providing Localization Elements and Methods of Use
|
|
US8114982B2
(en)
|
2006-12-06 |
2012-02-14 |
Albert Einstein College Of Medicine Of Yeshiva University |
Multi-microRNA methods and compositions
|
|
WO2008088858A2
(en)
|
2007-01-17 |
2008-07-24 |
The Johns Hopkins University |
Compositions and methods featuring micronas for treating neoplasia
|
|
WO2009012263A2
(en)
*
|
2007-07-18 |
2009-01-22 |
The Trustees Of Columbia University In The City Of New York |
Tissue-specific micrornas and compositions and uses thereof
|
|
EP2187896B1
(en)
|
2007-07-31 |
2016-01-13 |
The Board of Regents of The University of Texas System |
Inhibitors of mir-499 and mir-208b for use in the treatment of pathologic cardiac hypertrophy, heart failure or myocardial infarction
|
|
US20090148535A1
(en)
|
2007-12-06 |
2009-06-11 |
Minerva Biotechnologies Corporation |
Method for treating cancer using interference rna
|
|
JP2010094122A
(ja)
|
2008-06-12 |
2010-04-30 |
Keio Gijuku |
バイオマーカーとしてのマイクロｒｎａを用いた頭頸部腫瘍の診断・治療選択
|
|
US8729041B2
(en)
|
2008-12-03 |
2014-05-20 |
The Johns Hopkins University |
Compositions and methods for treating hepatic neoplasia
|
|
SG176716A1
(en)
|
2009-06-08 |
2012-01-30 |
Miragen Therapeutics |
CHEMICAL MODIFICATION MOTIFS FOR miRNA INHIBITORS AND MIMETICS
|
|
US8796238B2
(en)
|
2009-09-17 |
2014-08-05 |
Sigma-Aldrich Co. Llc |
Short RNA mimetics
|
|
US20120302626A1
(en)
*
|
2009-12-04 |
2012-11-29 |
Sandeep Dave |
Microrna and use thereof in identification of b cell malignancies
|
|
US8768630B2
(en)
*
|
2010-02-19 |
2014-07-01 |
The Regents Of The University Of Michigan |
miRNA target prediction
|
|
MX354217B
(es)
|
2010-05-14 |
2018-02-19 |
Dana Farber Cancer Inst Inc |
Composiciones y metodos para el tratamiento de leucemia.
|
|
ES2596977T3
(es)
|
2010-09-02 |
2017-01-13 |
Université de Mons |
Agentes útiles en el tratamiento de la distrofia muscular facioescapulohumeral
|
|
JP2014506789A
(ja)
|
2011-02-03 |
2014-03-20 |
マーナ セラピューティクス インコーポレイテッド |
ｍｉＲ−１２４の合成模倣体
|
|
SG10201600836PA
(en)
|
2011-02-03 |
2016-03-30 |
Mirna Therapeutics Inc |
Synthetic mimics of mir-34
|
|
EP2736539B1
(en)
|
2011-07-25 |
2017-08-23 |
Nationwide Children's Hospital, Inc. |
Recombinant virus products and methods for inhibition of expression of dux4
|
|
US20140242093A1
(en)
|
2011-07-29 |
2014-08-28 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject
|
|
KR20140091688A
(ko)
|
2011-10-06 |
2014-07-22 |
미라젠 세러퓨틱스 인코포레이티드 |
마이크로rna 조절에 의한 전신 에너지 항상성의 제어
|
|
TWI516267B
(zh)
|
2011-11-07 |
2016-01-11 |
臺北榮民總醫院 |
抑制癌症或腫瘤細胞之類癌幹細胞特性及抗化學及放射治療特性的醫藥組合物
|
|
WO2013120038A2
(en)
|
2012-02-10 |
2013-08-15 |
Regents Of The University Of Minnesota |
Morpholino targeting dux4 for treating fshd
|
|
WO2013120497A1
(en)
*
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
|
KR102213609B1
(ko)
*
|
2012-07-13 |
2021-02-08 |
웨이브 라이프 사이언시스 리미티드 |
키랄 제어
|
|
US11293064B2
(en)
*
|
2013-05-02 |
2022-04-05 |
Thomas Jefferson University |
Human miRNAs for use in diagnosis, prognosis, and therapy of human conditions and diseases
|
|
US9518300B2
(en)
|
2014-04-14 |
2016-12-13 |
Dana-Farber Cancer Institute, Inc. |
Composition and method for treating a hematological malignancy
|
|
MX375592B
(es)
|
2014-04-25 |
2025-03-06 |
The Children´S Medical Center Corp |
Composiciones y su uso para tratar hemoglobinopatias.
|
|
US10538763B2
(en)
*
|
2015-01-16 |
2020-01-21 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulation of DUX4
|
|
US20180305689A1
(en)
|
2015-04-22 |
2018-10-25 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
|
EP3314027A4
(en)
*
|
2015-06-29 |
2019-07-03 |
Caris Science, Inc. |
THERAPEUTIC OLIGONUCLEOTIDES
|
|
WO2017007886A2
(en)
|
2015-07-08 |
2017-01-12 |
Idera Pharmaceuticals, Inc. |
Compositions for inhibiting dux4 gene expression and uses thereof
|
|
EP3426781B1
(en)
*
|
2016-03-07 |
2024-06-26 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Micrornas and methods of their use
|
|
CA3019832C
(en)
*
|
2016-04-02 |
2023-05-09 |
Research Institute At Nationwide Children's Hospital |
Modified u6 promoter system for tissue specific expression
|
|
WO2019060432A2
(en)
*
|
2017-09-19 |
2019-03-28 |
Children's National Medical Center |
GAPMERS AND METHODS OF USING THE SAME FOR THE TREATMENT OF MUSCLE DYSTROPHY
|
|
AU2018345772B2
(en)
*
|
2017-10-02 |
2025-04-17 |
Research Institute At Nationwide Children's Hospital |
MiRNA detargeting system for tissue specific interference
|
|
US10676744B2
(en)
*
|
2017-10-13 |
2020-06-09 |
University Of South Carolina |
Modulation of adipose tissue macrophage phenotype by use of MicroRNA-30
|
|
US11268305B2
(en)
|
2018-05-17 |
2022-03-08 |
Kiekert Ag |
Latching system for a motor vehicle
|
|
WO2020028134A1
(en)
*
|
2018-07-30 |
2020-02-06 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for treating cancer
|
|
SG11202100928QA
(en)
|
2018-08-02 |
2021-02-25 |
Dyne Therapeutics Inc |
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
|
|
SG11202103938UA
(en)
*
|
2018-11-02 |
2021-05-28 |
Biomarin Tech Bv |
Bispecific antisense oligonucleotides for dystrophin exon skipping
|
|
WO2020203880A1
(ja)
|
2019-03-29 |
2020-10-08 |
田辺三菱製薬株式会社 |
Ｄｕｘ４の発現を調節するための化合物、方法及び医薬組成物
|
|
US20220364086A1
(en)
|
2019-07-12 |
2022-11-17 |
Daiichi Sankyo Company, Limited |
ANTISENSE OLIGONUCLEOTIDE CAPABLE OF ALTERING SPLICING OF DUX4 pre-mRNA
|
|
KR20220125801A
(ko)
|
2020-01-10 |
2022-09-14 |
다인 세라퓨틱스, 인크. |
근육 표적화 복합체 및 안면견갑상완 근육 이영양증을 치료하기 위한 그의 용도
|
|
WO2021188390A1
(en)
|
2020-03-19 |
2021-09-23 |
Avidity Biosciences, Inc. |
Compositions and methods of treating facioscapulohumeral muscular dystrophy
|
|
AU2021257213A1
(en)
|
2020-04-17 |
2022-11-03 |
Nevada Research & Innovation Corporation |
CRISPR-inhibition for facioscapulohumeral muscular dystrophy
|
|
GB202009618D0
(en)
|
2020-06-24 |
2020-08-05 |
Ucl Business Ltd |
Therapeutics for the treatment of FSHD
|
|
KR20230046297A
(ko)
|
2020-07-23 |
2023-04-05 |
다인 세라퓨틱스, 인크. |
근육 표적화 복합체 및 안면견갑상완 근육 이영양증을 치료하기 위한 그의 용도
|
|
CN116194470B
(zh)
|
2020-07-23 |
2025-10-03 |
达因疗法公司 |
肌肉靶向复合物及其用途
|
|
WO2022043566A1
(en)
|
2020-08-31 |
2022-03-03 |
Merck Patent Gmbh |
Method and device for manufacturing of solid oral dosage forms
|
|
WO2022045366A1
(en)
|
2020-08-31 |
2022-03-03 |
Modalis Therapeutics Corporation |
Method for treating facioscapulohumeral muscular dystrophy (fshd) by targeting dux4 gene
|
|
CA3189861A1
(en)
|
2020-09-01 |
2022-03-10 |
Sean Christopher DAUGHERTY |
Dux4 inhibitors and methods of use thereof
|
|
CA3189065A1
(en)
|
2020-09-11 |
2022-03-17 |
Arrowhead Pharmaceuticals, Inc. |
Rnai agents for inhibiting expression of dux4, compositions thereof, and methods of use
|
|
WO2022056269A1
(en)
|
2020-09-11 |
2022-03-17 |
Arrowhead Pharmaceuticals, Inc. |
Skeletal muscle delivery platforms and methods of use
|
|
JP2022055361A
(ja)
|
2020-09-28 |
2022-04-07 |
田辺三菱製薬株式会社 |
Ｄｕｘ４の発現を調節するための医薬組成物
|